Tahara S, Morooka T, Wang Z, Bezerra HG, Rollins AM, Simon DI, Costa MA.
Intravascular optical coherence tomography detection of atherosclerosis and inflammation in murine aorta. Arterioscler Thromb Vasc Biol. 2012 May;32(5):1150-7.

Tahara S, Bezerra HG, Kyono H, Carrigan T, Mehanna E, Wang W, Costa MA. Impact of acute gain on clinical outcomes of patients treated with sirolimus-eluting stent. - A sub-analysis study from the STLLR trial-. Circ J. 2011;75(9):2113-9. Epub 2011 Jul 14.

Tahara S, Chamie D, Baibars M, Alraies C, Costa M. Optical coherence tomography endpoints in stent clinical investigations: strut coverage.
Int J Cardiovasc Imaging. 2011 Feb;27(2):271-87.

Tahara S, Bezerra HG, Baibars M, Kyono H, Wang W, Pokras S, Mehanna E, Petersen CL, Costa MA. Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial. Heart. 2010 Oct;96(19):1574-8.

Naganuma T, Tsujita K, Mitomo S, Ishiguro H, Basavarajaiah S, Sato K, Kobayashi T, Obata J, Nagamatsu S, Yamanaga K, Komura N, Sakamoto K, Yamamoto E, Izumiya Y, Kojima S, Kaikita K, Ogawa H, Nakamura S. Impact of Chronic Kidney Disease on Outcomes after Percutaneous Coronary Intervention for Chronic Total Occlusions (From a Japanese Multicentre Registry). Am J Cardiol. in press.

Naganuma T, Kawamoto H, Onishi H, Nakamura S. Successful rotational atherectomy for a heavily calcified stenosis of the abdominal aorta in a case treated with transfemoral transcatheter aortic valve implantation. Kardiol Pol. in press.

Naganuma T, Kawamoto H, Panoulas VF, Latib A, Tanaka A, Mitomo S, Ruparelia N, Jabbour RJ, Chieffo A, Carlino, Montorfano M, Colombo A. Mid-term Clinical Outcomes of ABSORB Bioresorbable Vascular Scaffold versus Everolimus-eluting Stent for Coronary Bifurcation Lesions. Int J Cardiol. in press.

Naganuma T, Fujino Y, Mitomo S, Basavarajaiah S, Nakamura S. One-year follow-up optical coherence tomography after endovascular treatment with a new-generation zotarolimus-eluting stent for chronic mesenteric ischemia. Hellenic J Cardiol. in press.

Naganuma T, Kawamoto H, Takagi K, Yabushita H, Mitomo S, Watanabe Y, Shirai S, Araki M, Tada N, Yamanaka F, Yamamoto M, Onishi H, Nakamura S, Higashimori A, Tabata M, Mizutani K, Ueno H, Hayashida K. Can We Perform Rotational Atherectomy in Patients with Severe Aortic Stenosis? Substudy from OCEAN-TAVI Registry. Cardiovasc Revasc Med. 2017; 18: 356-360.

Naganuma T, Kawamoto H, Yabushita H, Nakao T, Nakamura S. Severe aortic stenosis with a large infra-aortic-annular aneurysm of ventricular septum treated with CoreValve. Can J Cardiol. 2017; 33: 688.e13-688.e15.

Naganuma T, Colombo A, Lesiak M, Capodanno D, Gori T, Nef H, Caramanno G, Naber C, Di Mario C, Ruparelia N, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Kawamoto H, Pyxaras S, Mattesini A, Münzel T, Tamburino C, Latib A. Bioresorbable Vascular Scaffold Use for Coronary Bifurcation Lesions: A substudy from GHOST EU registry. Catheter Cardiovasc Interv. 2017; 89: 47-56.

Naganuma T, Mitomo S, Yabushita H, Nakao T, Lazarevic A, Nakamura S. Buddy Wire Technique for Successful Transfemoral Transcatheter Aortic Valve Implantation through an Extremely Tortuous Abdominal Aorta: A Basic Technique in Asian Patients? AsiaIntervention. in press.

Naganuma T, Mitomo S, Yabushita H, Kawamoto H, Nakao T, Lazarevic A, Nakamura S. Kissing Balloon Inflation in the Aortic Valve and Left Main Stem: A Novel Coronary Protection Technique. Int J Cardiol. 2016; 223: 571-573.

Naganuma T, Mitomo S, Kin N, Nakamura S. Successful Anticoagulation Using Argatroban during Transcatheter Aortic Valve Implantation in a Patient with Heparin-induced Thrombocytopenia. A A Case Rep. 2016; 7: 158-160.

Naganuma T, Mitomo S, Nakamura S, Akita M, Nakao T, Nakamura S. Transcatheter Balloon Expandable Aortic Valve Implantation through Aorto-femoral Bypass Graft. Intern Med. 2016; 55: 1459-1461.

Naganuma T, Latib A, Costopoulos C, Oreglia J, Testa L, De Marco F, Candreva A, Chieffo A, Naim C, Montorfano M, Bedogni F, Colombo A. Drug-eluting Balloon versus Second Generation Drug-eluting Stent for the Treatment of Restenotic Lesions Involving Coronary Bifurcations. EuroIntervention. 2016; 11: 989-995.

Naganuma T, Ishiguro H, Panoulas VF, Fujino Y, Mitomo S, Kawamoto H, Nakamura S, Colombo A. Which child catheter should we choose to deliver a bulky bioresorbable vascular scaffold? Int J Cardiol. 2015; 203: 781-782.

Naganuma T, Fujino Y, Tahara S, Mitomo S, Basavarajaiah S, Nakamura S. Extremely Late Catch-up Phenomenon after First-generation Sirolimus-eluting Stent in Left Main Stem: Insights from Optical Coherence Tomography. JACC Cardiovasc Interv. 2015; 8: e237-9.

Naganuma T, Latib A, Wahab MA, Danenberg H, Panoulas VF, Cota L, Barbanti M, Baumgartner H, Finkelstein A, Legrand V, Suárez de Lezo J, Kefer J, Messika-Zeitoun D, Richardt G, Stabile E, Kaleschke G, Vahanian A, Laborde JC, Leon MB, Webb JG, Maisano F, Alfieri O, Colombo A. Treatment and Clinical Outcomes of Transcatheter Heart Valve Thrombosis. Circ Cardiovasc Interv. 2015; 8.

Naganuma T, Latib A, Sgueglia GA, Menozzi A, Castriota F, Micari A, Cremonesi A, De Felice F, Marchese A, Tespili M, Presbitero P, Panoulas VF, Buffoli F, Tamburino C, Varbella F, Colombo A. A 2-year Follow-up of a Randomized Multicenter Study Comparing a Paclitaxel Drug-Eluting Balloon With a Paclitaxel-Eluting Stent in Small Coronary Vessels: The BELLO Study. Int J Cardiol. 2015; 184: 17-21.

Naganuma T, Takagi K, Fujino Y, Kobayashi T, Mitomo S, Akita, M, Nakao T, Nakamura S. Valsalva Sinus Perforation into the Right Atrium due to Infective Endocarditis of a Transcatheter Heart Valve. Circ J. 2015; 79: 1133-5.

Naganuma T, Panoulas VF, Latib A, Kawamoto H, Sato K, Miyazaki T, Colombo A. 1-year follow-up optical coherence tomography of a "hybrid" neo-carina after T-stenting with small protrusion technique using a bioresorbable vascular scaffold and a metallic stent. JACC Cardiovasc Interv. 2015; 8: e101-3.

Naganuma T, Ishiguro H, Takagi K, Fujino Y, Mitomo S, Nakamura S, Nakamura S, Colombo A. Provisional T stenting with Bioresorbable Vascular Scaffolds in Vivo: Insights from Optical Frequent Domain Imaging. JACC Cardiovasc Interv. 2015; 8: 635-7.

Naganuma T, Chieffo A, Takagi K, Panoulas VF, Mitomo S, Sticchi A, Latib A, Miyazaki T, Sato K, Costopoulos C, Fujino Y, Montorfano M, Carlino M, Nakamura S, Colombo A. First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: The Milan and New-Tokyo (MITO) registry. Catheter Cardiovasc Interv. 2015; 85: E63-9.

Naganuma T, Latib A, Panoulas VF, Sato K, Miyazaki T, Colombo A. One-year follow-up optimal coherence tomography after implantation of bioresorbable vascular scaffolds for a chronic coronary total occlusion. JACC Cardiovasc Interv. 2014; 7: e157-9.

Naganuma T, Latib A, Panoulas VF, Sato K, Miyazaki T, Colombo A. Why do we need post-dilation after implantation of bioresorbable vascular scaffold even for a soft lesion? JACC Cardiovasc Interv. 2014; 7: 1070-2.

Naganuma T, Latib A, Panoulas VF, Sato K, Miyazaki T, Colombo A. Delayed Disruption of a Bioresorbable Vascular Scaffold. JACC Cardiovasc Imaging. 2014; 7: 845-7.

Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A. Long-term Clinical Outcomes following Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Ostial/midshaft Lesions in Unprotected Left Main Coronary Artery from the DELTA Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Treatment. JACC Cardiovasc Interv. 2014; 7: 354-61.

Naganuma T, Latib A, Costopoulos C, Takagi K, Naim C, Sato K, Miyazaki T, Kawaguchi M, Panoulas VF, Basavarajaiah S, Figini F, Chieffo A, Montorfano M, Carlino M, Colombo A. The Role of Intravascular Ultrasound and Quantitative Angiography in the Functional Assessment of Intermediate Coronary Lesions: Correlation with Fractional Flow Reserve. Cardiovasc Revasc Med. 2014; 15: 3-7.

Naganuma T, Latib A, Ielasi A, Panoulas VF, Sato K, Miyazaki T, Colombo A. No more metallic cages: An attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel. Int J Cardiol. 2014; 172: 618-9.

Naganuma T, Costopoulos C, Latib A, Sato K, Miyazaki T, Colombo A. Feasibility and Efficacy of Bioresorbable Vascular Scaffolds Use for the Treatment of In-stent Restenosis and a Bifurcation Lesion in a Heavily Calcified Diffusely Diseased Vessel. JACC Cardiovasc Interv. 2014; 7: e45-6.

Naganuma T, Latib A, Basavarajaiah S, Chieffo A, Figini F, Carlino M, Montorfano M, Godino C, Ferrarello S, Hasegawa T, Kawaguchi M, Nakamura S, Colombo A. The long-term clinical outcome of T-stenting and small protrusion technique for coronary bifurcation lesions. JACC Cardiovasc Interv. 2013; 6: 554-61.

Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A. Long-term Clinical Outcomes following Percutaneous Coronary Intervention for Ostial/midshaft Lesions versus Distal Bifurcation Lesions in Unprotected Left Main Coronary Artery from the DELTA Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Treatment. JACC Cardiovasc Interv. 2013; 6: 1242-9.

Naganuma T, Chieffo A, Basavarajaiah S, Takagi K, Costopoulos C, Latib A, Carlino M, Montorfano M, Bernelli C, Nakamura S, Colombo A. Single-stent crossover technique from distal unprotected left main coronary artery to the left circumflex artery. Catheter Cardiovasc Interv. 2013; 82: 757-64.

Naganuma T, Costopoulos C, Latib A, Colombo A. Aortic regurgitation after transcatheter aortic valve implantation. Expert Rev Cardiovasc Ther. 2013; 11: 1089-92.

Naganuma T, Latib A, Agricola E, Alfieri O, Spagnolo P, Colombo A, Maisano F. Late downward dislocation of a balloon expandable valve into the left ventricular outflow tract following transfemoral transcatheter aortic valve implantation. Circ J. 2013; 77: 1345-7.

Naganuma T, Basavarajaiah S, Latib A, Costopoulos C, Colombo A. Use of BVS in a chronic total occlusion with bifurcation lesion. Int J Cardiol. 2013; 167: e129-31.

Naganuma T, Latib A, Costopoulos C, Miyazaki T, Sato K, Colombo A. Evolution of Bioresorbable Vascular Scaffolds and their Role in Everyday Practice. Revista Argentina de Cardioangiología Intervencionista. 2013 December.

Naganuma T, Dote K, Kato M, Sasaki S, Ueda K, Kono Y, Watanabe Y, Kajikawa M, Yokoyama H. Pulmonary embolism due to internal jugular vein thrombosis without an indwelling catheter. Intern Med. 2009; 48: 433-36.

Naganuma T, Dote K, Kato M. Left atrial appendage thrombi revealed by coronary angiography. Can J Cardiol. 2009; 25: e427.

Naganuma T, Dote K, Kato M, Sasaki S, Ueda K, Nakano Y, Watanabe Y. Intracoronary thrombus in acute myocardial infarction after pulse infusion thrombolysis, observed by intravascular ultrasound. Jpn J Interv Cardiol. 2008; 23: 188-92.

Yabushita H, Goto S. Validation of DAPT Score (Dual Antiplatelet Therapy) in East Asian Patients.Circulation. 2018 Feb 6;137(6):563-566.

Yabushita H, Takagi K, Tahara S, Fujino Y, Warisawa T, Kawamoto H, Watanabe Y, Mitomo S, Karube K, Matsumoto T, Sato T, Naganuma T, Kobayashi T, Ishiguro H, Fukino K, Kurita N, Nakamura S, Hozawa K, Nakamura S.
Impact of rotational atherectomy on heavily calcified, unprotected left main disease. Circ J. 2014;78(8):1867-72. Epub 2014 Jun 12.

Watanabe Y, Takagi K, Naganuma T, et al.: Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions. Int J Cardiol. 2017:240:108-113.

Watanabe Y, Fujino Y, Ishiguro H, et al.: Long-term outcomes of a recanalized thrombus treated with a paclitaxel-coated balloon: insights from optical coherence tomography. Coron Artery Dis.

Watanabe Y, Fujino Y, Ishiguro H, et al.: Double-barrel coronary artery after subintimal stenting for chronic total occlusion. Cardiovascular revascularization medicine : including molecular interventions. 2017:18:361-363.

Watanabe Y, Fujino Y, Ishiguro H, et al.: Recanalized Thrombus Treated With a Paclitaxel-Coated Balloon: Insights from Optical Coherence Tomography. JACC Cardiovascular interventions. 2016:9:618-620.

Watanabe Y, Takagi K, Naganuma T, et al.: Comparison of early- and new-generation drug-eluting stent implantations for ostial right coronary artery lesions. Cardiovasc Ther. 2017:35.

Watanabe Y, Naganuma T, Nakao T, et al.: A Calcified Amorphous Tumor Originating in the Sinus of Valsalva. Echocardiography. 2016:33:796-798.

Watanabe Y, Naganuma T, Nakao T, et al.: Calcified amorphous tumor of the left atrial appendage. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology. 2016:25:237-239.

Watanabe Y, Naganuma T, Hosawa K, et al.: Successful endovascular treatment with a cutting balloon for traumatic obstruction of an external iliac artery in a young male. Int J Cardiol. 2015:201:339-341.

Watanabe Y, Takagi K, Nakamura S: Acute and chronic total occlusion of the left circumflex artery following unprotected left main stenting: two contrasting cases. Coron Artery Dis. 2015:26:548-550.

由木先生

Yuki H, Naganuma T, Nakazawa G, Nakamura S. Pathological assessment of very late bare metal stent thrombosis in the left main coronary artery: a case report. Eur Heart J Case Rep. 2021;5:ytaa572. doi: 10.1093/ehjcr/ytaa572

Yuki H, Kinoshita D, Suzuki K, Niida T, Nakajima A, Seegers LM, Vergallo R, Fracassi F, Russo M, Di Vito L, et al. Layered plaque and plaque volume in patients with acute coronary syndromes. J Thromb Thrombolysis. 2023. doi: 10.1007/s11239-023-02788-9

Yuki H, Sugiyama T, Suzuki K, Kinoshita D, Niida T, Nakajima A, Araki M, Dey D, Lee H, McNulty I, et al. Coronary Inflammation and Plaque Vulnerability: A Coronary Computed Tomography and Optical Coherence Tomography Study. Circ Cardiovasc Imaging. 2023:e014959. doi: 10.1161/CIRCIMAGING.122.014959

Park S, Yuki H, Niida T, Suzuki K, Kinoshita D, McNulty I, Broersen A, Dijkstra J, Lee H, Kakuta T, et al. A novel deep learning model for a computed tomography diagnosis of coronary plaque erosion. Sci Rep. 2023;13:22992. doi: 10.1038/s41598-023-50483-9

Yuki H, Isselbacher E, Niida T, Suzuki K, Kinoshita D, Fujimoto D, Lee H, McNulty I, Nakamura S, Kakuta T, et al. Protruding Aortic Plaque and Coronary Plaque Vulnerability. J Am Heart Assoc. 2024:e032742. doi: 10.1161/jaha.123.032742

Yuki H, Sundt TM, Niida T, Suzuki K, Kinoshita D, Fujimoto D, Dey D, Lee H, McNulty I, Naganuma T, et al. Level of Perivascular Inflammation Is Significantly Lower Around the Left Internal Mammary Artery Than Around Native Coronary Arteries. J Am Heart Assoc. 2024;13:e033224. doi: 10.1161/jaha.123.033224

Niida T, Yuki H, Suzuki K, Kinoshita D, Fujimoto D, Nakajima A, McNulty I, Lee H, Tanriverdi K, Nakamura S, et al. Proteomics associated with coronary high-risk plaques by optical coherence tomography. J Thromb Thrombolysis. 2024;57:204-211. doi: 10.1007/s11239-023-02938-z

清水先生

著書

Shimizu W, Ohe T, Nagata S, Shimomura K: Arrhythmogenic right ventricular dysplasia: Clinical features, diagnosis, treatment, and prognosis. in Sekiguchi M, Olsen E G L (eds): Cardiomyopathy Update 5. Prognosis and treatment of cardiomyopathies and myocarditis: p. 295-310, University of Tokyo Press, 1994

Shimizu W, Ohe T, Antzelevitch C: Early afterdepolarizations and polymorphic ventricular arrhythmias in acquired and congenital long QT syndrome: Observations from clinical and experimental studies. in Franz M R (ed): Monophasic Action Potentials. Bridging Cell and Bedside. p. 641-658, Futura Publishing Company, Inc., NY, 2000

Shimizu W: Acquired forms of Brugada syndrome. in Antzelevitch C (ed): The Brugada Syndrome: From bench to bedside, Chapter 14, p. 166-177, Blackwell Futura, UK, 2004

Shimizu W, Ackerman MJ: Chapter 28, Provocative testing in inherited arrhythmias. in Gussak I, Antzelevitch C, Wilde A, Friedman P, Ackerman MJ, Shen WK (eds): Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention, p. 424-433, Springer, UK, 2007

Shimizu W: Chapter 50, Acquired form of Brugada syndrome. in Gussak I, Antzelevitch C, Wilde A, Friedman P, Ackerman MJ, Shen WK (eds): Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention, p. 719-728, Springer, UK, 2007

Shimizu W, Antzelevitch C: Long QT syndrome. in Lang F (ed): Molecular mechanisms of disease: an Encyclopedic reference, p -, Springer, UK, 2011

Shimizu W: Diagnostic evaluation of long QT syndrome. in Priori SG (ed): Cardiac electrophysiology clinics. volume 4, p. 29-37, Elsevier, Philadelphia, 2012

Shimizu W, Ackerman MJ: Chapter 50, Provocative (drug) testing in inherited arrhythmias. in Gussak I, Antzelevitch C, Wilde A, Powell B, Ackerman MJ, Shen WK (eds): Electrical Diseases of the Heart (Second edition): Genetics, Mechanisms, Treatment, Prevention, Part IV. Clinical rhythmology: Diagnostic methods and tools, p. -, Springer, UK, Oxford, 2013 (in press)

Shimizu W: Chapter 40, Acquired form of Brugada syndrome. in Gussak I, Antzelevitch C, Wilde A, Powell B, Ackerman MJ, Shen WK (eds): Electrical Diseases of the Heart (Second edition): Genetics, Mechanisms, Treatment, Prevention, Part III. Secondary Hereditary and Acquired Cardiac Channelopathies, and Sudden Cardiac Death, p. -, Springer, UK, Oxford, 2013

原著・総説

Shimizu W, Ohe T, Kurita T, Takaki H, Aihara N, Kamakura S, Matsuhisa M, Shimomura K: Early afterdepolarizations induced by isoproterenol in patients with congenital long QT syndrome. Circulation 84: 1915-1923, 1991

Shimizu W, Ohe T, Kurita T, Shimomura K: Differential response of QTU interval to exercise, isoproterenol, and atrial pacing in patients with congenital long QT syndrome. PACE 14: 1966-1970, 1991

Shimizu W, Ohe T, Shimomura K: Ventricular tachycardia originating from the right ventricular free wall in a patient with old myocardial infarction. CHEST 100: 276-277, 1991

Shimizu W, Tanaka K, Suenaga K, Wakamoto A: Bradycardia-dependent early afterdepolarizations in a patient with QTU prolongation and Torsade de Pointes in association with marked bradycardia and hypokalemia. PACE 14: 1105-1111, 1991

Shimizu W, Ohe T, Kurita T, Takaki H, Aihara N, Kamakura S, Matsuhisa M, Shimomura K: Effects of a combination of disopyramide and mexiletine on the anterograde accessory pathway conduction in patients with Wolff-Parkinson-White syndrome. Eur Heart J 13: 261-268, 1992

Shimizu W, Tsuchioka Y, Karakawa S, Nagata K, Mukai J, Yamagata T, Matsuura H, Kajiyama G, Matsuura Y: Differential effect of pharmacological autonomic blockade on some electrophysiological properties of the human ventricle and atrium. Br Heart J 71: 34-37, 1994

Shimizu W, Kamakura S, Ohe T, Kurita T, Takaki H, Aihara N, Shimomura K: Diagnostic value of recovery time measured by body surface mapping in patients with congenital long QT syndrome. Am J Cardiol 74: 780-785, 1994

Shimizu W, Ohe T, Kurita T, Tokuda T, Shimomura K: Epinephrine-induced ventricular premature complexes due to early afterdepolarizations and effects of verapamil and propranolol in a patient with congenital long QT syndrome. J Cardiovasc Electrophysiol 5: 438-444, 1994

Shimizu W, Ohe T, Kurita T, Kawade M, Arakaki Y, Aihara N, Kamakura S, Kamiya T, Shimomura K: Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome. J Am Coll Cardiol 26: 1299-1309, 1995

Shimizu W, Kurita T, Suyama K, Aihara N, Kamakura S, Shimomura K: Reverse use dependence of human ventricular repolarization by chronic oral sotalol in monophasic action potential recordings. Am J Cardiol 77: 1004-1008, 1996

Shimizu W, Yamada K, Arakaki Y, Kamiya T, Shimomura K: Monophasic action potential recordings during T wave alternans in congenital long QT syndrome. Am Heart J 132: 699-701, 1996

Shimizu W, Kamakura S, Arakaki Y, Kamiya T, Shimomura K: T wave alternans in idiopathic long QT syndrome: Insight from body surface mapping. PACE 19: 1130-1133, 1996

Shimizu W, Antzelevitch C: Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 and LQT3 models of the long QT syndrome. Circulation 96: 2038-2047, 1997

Shimizu W, Kamakura S, Kurita T, Suyama K, Aihara N, Shimomura K: Influence of epinephrine, propranolol and atrial pacing on spatial distribution of recovery time measured by body surface mapping in congenital long QT syndrome. J Cardiovasc Electrophysiol 8: 1102-1114, 1997

Shimizu W, Kurita T, Inagaki M, Suyama K, Aihara N, Kamakura S, Kosakai Y, Isobe F, Shimomura K: Electrophysiological changes of arrhythmogenic substrate following Maze procedure in patients with lone and paroxysmal atrial fibrillation. Jpn Circ J 61: 988-996, 1997

Shimizu W, Kurita T, Matsuo K, Suyama K, Aihara N, Kamakura S, Towbin J A, Shimomura K: Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long QT syndrome. Circulation 97: 1581-1588, 1998

Shimizu W, Antzelevitch C: Cellular basis for the electrocardiographic features of the LQT1 form of the long QT syndrome. Effects of β adrenergic agonists, antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 98: 2314-2322, 1998

Shimizu W, Antzelevitch C: Cellular and ionic basis for T wave alternans under long QT conditions. Circulation 99: 1499-1507, 1999

Shimizu W, MacMahon B, Antzelevitch C: Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsade de pointes in models of acquired and congenital long QT syndrome. J Cardiovasc Electrophysiol 10: 154-164, 1999

Shimizu W, Antzelevitch C: Cellular basis for long QT, transmural dispersion of repolarization and Torsade de Pointes in the long QT syndrome. J Electrocardiol 32: 177-184, 1999

Shimizu W, Antzelevitch C: Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 35: 778-786, 2000

Shimizu W, Antzelevitch C: Effects of a K+ channel opener to reduce transmural dispersion of repolarization and prevent Torsade de Pointes in LQT1, LQT2 and LQT3 models of the long-QT syndrome. Circulation 102: 706-712, 2000

Shimizu W, Matsuo K, Takagi M, Tanabe Y, Aiba T, Taguchi A, Suyama K, Kurita T, Aihara N, Kamakura S: Body surface distribution and response to drugs of ST segment elevation in the Brugada syndrome: Clinical implication of 87-leads body surface potential mapping and its application to 12-leads electrocardiograms. J Cardiovasc Electrophysiol 11: 396-404, 2000

Shimizu W, Antzelevitch C, Suyama K, Kurita T, Taguchi A, Aihara N, Takaki H, Sunagawa K, Kamakura S: Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol 11: 1320-1329, 2000

Shimizu W: Editorial comment, T wave alternans: From cell to clinical. J Cardiovasc Electrophysiol 12: 428-430, 2001

Shimizu W, Aiba T, Kurita T, Kamakura S: Paradoxical abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST segment elevation. J Cardiovasc Electrophysiol 12: 1418-1421, 2001

Shimizu W, Kamakura S: Catecholamines in children with congenital long QT syndrome and Brugada syndrome. J Electrocardiol 34: 173-175, 2001

Shimizu W, Tanabe Y, Aiba T, Inagaki M, Kurita T, Suyama K, Nagaya N, Taguchi A, Aihara N, Sunagawa K, Nakamura K, Ohe T, Towbin J A, Priori S G, Kamakura S: Differential effects of β-blockade on dispersion of repolarization in absence and presence of sympathetic stimulation between LQT1 and LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol 39; 1984-1991, 2002

Shimizu W, Satomi K, Kamakura S: Visualization of activation and repolarization in congenital long QT syndrome. Heart 88; 190, 2002

Shimizu W: Effects of sympathetic stimulation on various repolarization indices in the congenital long QT syndrome. Ann Noninvasive Electrocardiol 4: 332-342, 2002

Shimizu W, Noda T, Takaki H, Kurita T, Nagaya N, Satomi K, Suyama K, Aihara N, Kamakura S, Echigo S, Nakamura K, Sunagawa K, Ohe T, Towbin J A, Napolitano C, Priori S G: Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long QT syndrome. J Am Coll Cardiol 41: 633-642, 2003

Shimizu W: Genotype-specific clinical manifestation in long QT syndrome. Expert Review of Cardiovascular Therapy 1: 401-409, 2003

Shimizu W: Editorial comment, Gender difference and drug challenge in Brugada syndrome. J Cardiovasc Electrophysiol 15: 70-71, 2004

Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T, Suyama K, Aihara N, Sunagawa K, Echigo S, Miyamoto Y, Yoshimasa Y, Nakamura K, Ohe T, Towbin J A, Priori S G, Kamakura S: Diagnostic value of epinephrine test for genotyping LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Heart Rhythm 1: 276-283, 2004

Shimizu W, Horie M, Ohno S, Takenaka K, Yamaguchi M, Shimizu M, Washizuka T, Aizawa Y, Nakamura K, Ohe T, Aiba T, Miyamoto Y, Yoshimasa Y, Towbin J A, Priori S G, Kamakura S: Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in LQT1 form of congenital long QT syndrome - Multi-center study in Japan -. J Am Coll Cardiol 44: 117-125, 2004

Shimizu W, Aiba T, Antzelevitch C: Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. - Long QT syndrome and Brugada syndrome -. Curr Pharm Design 11: 1561-1572, 2005

Shimizu W: The long QT syndrome: Therapeutic implications of a genetic diagnosis. Cardiovasc Res 67: 347-356, 2005

Shimizu W, Aiba T, Kamakura S: Mechanisms of disease: current understanding and future challenges in Brugada syndrome. Nat Clin Pract Cardiovasc Med 2, 408-414, 2005

Shimizu W: Acquired forms of the Brugada syndrome. J Electrocardiol 38 Suppl: 22-25, 2005

Shimizu W: The Brugada syndrome. - An update -. Internal Med 44: 1224-1231, 2005

Shimizu W: Editorial comment. Does an overlap syndrome really exist between Brugada syndrome and progressive cardiac conduction defect (Lenegre syndrome)? J Cardiovasc Electrophysiol 17: 276-278, 2006

Bezzina CR*, Shimizu W*, Yang P*, Koopmann TT, Tanck MWT, Miyamoto Y, Kamakura S, Roden DM, Wilde AAM: A common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction. Circulation 113: 338-344, 2006
*These 3 authors equally contributed

Shimizu W, Matsuo K, Kokubo Y, Satomi K, Kurita T, Noda T, Nagaya N, Suyama K, Aihara N, Kamakura S, Inamoto N, Akahoshi M, Tomoike H: Sex hormone and gender difference. - Role of testosterone on male predominance in Brugada syndrome. J Cardiovasc Electrophysiol 18: 415-421, 2007

Shimizu W, Aiba T, Kamakura S: Mechanism and new findings in the Brugada syndrome. Circ J 71: (Suppl A) A32-A39, 2007

Shimizu W: Editorial Commentary. Proarrhythmic effect of altered ventricular activation sequence in patients with permanent pacemaker. Heart Rhythm 4: 1487-1488, 2007

Moss AJ*, Shimizu W*, Wilde AAM*, Towbin JA*, Zareba Z, Robinson JL, Qi M, Vincent GM, Ackerman MJ, Kaufman ES, Hofman N, Seth R, Kamakura S, Miyamato Y, Goldenberg I, Andrews ML, McNitt S: Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 115: 2481-2489, 2007
*These 4 authors equally contributed

Shimizu W: Genetics of congenital long QT syndrome and Brugada syndrome. Future Cardiology 4: 379-389, 2008

Shimizu W: Clinical impact of genetic studies in lethal inherited cardiac arrhythmias. Circ J 72: 1926-1936, 2008

Shimizu W, Moss AJ, Wilde AAM, Towbin JA, Ackerman MJ, January C, Tester DJ, Zareba W, Robinson JL, Qi M, Vincent GM, Kaufman ES, Hofman N, Noda T, Kamakura S, Miyamoto Y, MD, Shah S, Amin V, Goldenberg I, Andrews ML, McNitt S: Genotype-phenotype aspects of type-2 long-QT syndrome. J Am Coll Cardiol 54: 2052-2062; 2009

Shimizu W: Arrhythmias originating from the RVOT: How to distinguish “malignant” from “benign”? Heart Rhythm 6: 1507-1511, 2009

Shimizu W: Editorial Commentary. Diagnostic values of bipolar precordial leads in Brugada syndrome: More accurate, more simple, or more theoretical? Heart Rhythm 7: 216-217, 2010

Shimizu W: How the knowledge of genetic "makeup" and cellular data can affect the analysis of repolarization in surface ECG. J Electrocardiol 43: 583-587, 2010

Shimizu W, Horie M: Phenotypical manifestations of mutations in genes encoding subunits of cardiac potassium channels. Circ Res 109: 97-109, 2011

Shimizu W: Clinical features of Brugada syndrome. J Arrhythmia 29: 65-70, 2013

Shimizu W: Update of diagnosis and management in inherited cardiac arrhythmias. Circ J 77(12): 2867-2872, 2013

Shimizu W: Editorial comment. Importance of clinical analysis in this era of new technology of molecular genetic screening. J Am Coll Cardiol: 64(1): 80-82, 2014

Shimizu W: Clinical and genetic diagnosis for inherited cardiac arrhythmias. J Nippon Med Sch. 81(4):203-210, 2014

Shimizu W: Where does heterogeneity exist in ventricular tachyarrhythmias? Heart Rhythm. 12(6):1304-1305, 2015

Hayashi M*, Shimizu W*, Albert CM: The spectrum of epidemiology underlying sudden cardiac death. Circ Res. 116(12):1887-1906, 2015
*Equally contributed

Wilde AA*, Moss AJ*, Kaufman ES*, Shimizu W*, Peterson DR, Benhorin J, Lopes C, Towbin JA, Spazzolini C, Crotti L, Zareba W, Goldenberg I, Kanters JK, Robinson JL, Qi M, Hofman N, Tester DJ, Bezzina C, Alders M, Aiba T, Kamakura S, Miyamoto Y, Andrews ML, McNitt S, Polonsky B, Schwartz PJ, Ackerman MJ: Clinical aspects of type 3 long QT syndrome: An international multicenter study. Circulation. 134(12): 872-882, 2016
*These 4 authors equally contributed

Yamagata K*, Horie M, Aiba T, Ogawa S, Aizawa Y, Ohe T, Yamagishi M, Makita N, Sakurada H, Tanaka T, Shimizu A, Hagiwara N, Kishi R, Nakano Y, Takagi M, Makiyama T, Ohno S, Fukuda K, Watanabe H, Morita H, Hayashi K, Fukushima-Kusano K, Kamakura S, Yasuda S, Ogawa H, Miyamoto Y, Kapplinger J, Ackerman M, Shimizu W*: Genotype-phenotype correlation of SCN5A mutation for clinical and electrocardiographic characteristics of probands with Brugada Syndrome: A Japanese multicenter registry. Circulation. 135(23):2255-2270, 2017
*Equally contributed

Shimizu W, Kubota Y, Hoshika Y, Mozawa K, Tara S, Tokita Y, Yodogawa K, Iwasaki YK, Yamamoto T, Takano H, Tsukada Y, Asai K, Miyamoto M, Miyauchi Y, Kodani E, Ishikawa M, Maruyama M, Ogano M, Tanabe J; EMBODY trial investigators: Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial. Cardiovasc Diabetol. 19(1):148. 2020

Shimizu W: Extrinsic sex hormones rather than gender itself contribute directly to the electrocardiographic phenotype. Heart Rhythm. 18(7):1210-1211. 2021

Ono K, Iwasaki Y, Shimizu W: JCS/JHRS Guideline: Rivaroxaban Not Recommended for Patients With Nonvalvular Atrial Fibrillation and High Bleeding Risk – Reply. Circ J. doi: 10.1253/circj.CJ-22-0285, 2022

Shimizu W, Yamashita T, Masaharu Akao M, Atarashi H, MD, Ikeda T, Koretsune Y, Okumura K, Suzuki S, Tsutsui H, Toyoda K, Hirayama A, Yasaka M, Yamaguchi T, Teramukai S, Kimura T, Morishima Y, Takita A, Inoue H; Renal Function and Clinical Outcomes Among Elderly Patients With Nonvalvular Atrial Fibrillation From ANAFIE. JACC Asia. 3(3):475-487. 2023
https://doi.org/10.1016/j.jacasi.2023.02.002

Shimizu W, Uchiyama S, Atarashi H, Inoue H, Kitazono T, Yamashita T, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Shimokawa H: Effectiveness and safety of reduced-dose rivaroxaban for elderly patients with non-valvular atrial fibrillation: A subanalysis of the EXPAND study. Int J Cardiol. j.ijcard.2023.131290. doi: 2023

Shimizu W, Kusumoto FM, Agbayani MF, Apiyasawat S, Chen M, Ching CK, Choi JI, Dan Do VB, Hanafy DA, Hurwitz JL, Johar S, Kalman JM, Khan AHH, Khmao P, Krahn AD, Ngarmukos T, Binh Nguyen ST, Nwe N, Oh S, Soejima K, Stiles MK, Tsao HM, Tseveendee S: Statement from the Asia Summit: Current state of arrhythmia care in Asia. Heart Rhythm O2. 4(11):741-755. 2023. doi: 10.1016/j.hroo.2023.08.005. eCollection 2023 Nov.